Categoría:
FARMACOTERAPIA : Sistema nervioso : Antiparkinsonianos
Recursos:
The Australian Prescriber 1994;17;21 - Dopamine - clinical applications i. Neurology
The current treatments of Parkinson's disease aim to improve central dopaminergic neurotransmission. This may be achieved by using a prodrug (levodopa), directly-acting agonists or inhibitors of dopamine metabolism
http://www.australianprescriber.com/magazines/17/1/21/3/
World of Drug Information - Volume 9, Issue 2 - June 1998 - University of Iowa.
Parkinson's Disease: New Therapeutic Alternatives. Three of the new medications are dopamine agonists--pramipexole (Mirapex®) and ropinirole (Requip®), and cabergoline (Cabsar®, Dostinex®), which is available in Europe ...
http://www.uiowa.edu/~idis/wodjun98.htm
Esta web está
dirigida únicamente a profesionales sanitarios.
Web de tipo personal no ligada
a ninguna entidad pública ni privada | Quiénes
somos |
INFOMEDICAMENTO.NET - España -
Útima modificacion:
10/09/2011.